Covered recipient · General Payments record
VINH SON TRAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,278.69
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $179.90 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Dynavax Technologies Corporation | $52.08 | 2 |
| ABBVIE INC. | $32.84 | 2 |
| Daiichi Sankyo Inc. | $21.80 | 1 |
| Novo Nordisk AS | $20.45 | 1 |
| GlaxoSmithKline, LLC. | $19.77 | 1 |
| Abbott Laboratories | $18.88 | 1 |
| Neurelis, Inc. | $14.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.88 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125317513 | CMS |
| ABBVIE INC. | $19.34 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106240404 | CMS |
| ABBVIE INC. | $13.50 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106240406 | CMS |
| Daiichi Sankyo Inc. | $21.80 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089491998 | CMS |
| Dynavax Technologies Corporation | $26.04 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082143827 | CMS |
| Dynavax Technologies Corporation | $26.04 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082145627 | CMS |
| GlaxoSmithKline, LLC. | $19.77 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116516786 | CMS |
| Neurelis, Inc. | $14.08 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145657227 | CMS |
| Novo Nordisk Inc | $20.45 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097718229 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.